Nutriband (NTRB) Stock: Buy, Sell, or Hold?
NTRB - Nutriband Inc. Common Stock
$6.20
0.06 (1.00%)
▲
5d:
-1.09%
30d:
-15.63%
90d:
+108.1%
BUY
MODERATE Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Dec 09, 2026
Get Alerted When NTRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NTRB shows positive signals but monitor for confirmation. Market pricing in 12.1% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: NTRB shows positive signals but monitor for confirmation. Market pricing in 12.1% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.10
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$3.78
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NTRB is currently trading at $6.20, which is considered slightly low relative to its 30-day fair value range of $6.19 to $7.82. From a valuation perspective, the stock is trading at a premium (Forward PE: 4.2) compared to its historical average (3.0). At these levels, the market is pricing in 12.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NTRB is in a strong uptrend. Immediate support is located at $5.65, while resistance sits at $6.82.
Market Sentiment: NTRB scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $15.00 (+144.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NTRB is in a strong uptrend. Immediate support is located at $5.65, while resistance sits at $6.82.
Market Sentiment: NTRB scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $15.00 (+144.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$6.19 -
$7.82
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 144.3% below Wall St target ($15.00)
- NEUTRAL: Trading at premium valuation - market expects 12.1% growth which is achievable
- BULLISH: Bottoming setup score 65/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$6.19 -
$7.82
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$5.65
Resistance Level
$6.82
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.23
Wall Street Target
$15.00
(+144.3%)
Revenue Growth (YoY)
-29.7%
Valuation Premium vs History
+12.1% premium
PE vs Historical
4.2 vs 3.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+12.1%
(market-implied from PE analysis)
1-Year Target
$6.88
(+12%)
2-Year Target
$7.72
(+26%)
3-Year Target
$8.65
(+41%)
3-Yr Target (if PE normalizes)
(PE: 4→3)
PE COMPRESSION
$6.13
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: October 22, 2026 10:46 AM ET
Data refreshes hourly during market hours. Next update: 11:46 AM
Data refreshes hourly during market hours. Next update: 11:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$571 | 50 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
27 analysts |
$436 | 47 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$369 | 50 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$307 | 51 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
18 analysts |
$144 | 71 BUY |
